MEDICAL RECOMMENDATIONS

Archived 43: Summary of NACI statement of August 19, 2022: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age

National Advisory Committee on ImmunizationImmunization2022Archived document

ASEM documentary overview

Official National Advisory Committee on Immunization document (2022) on “Archived 43: Summary of NACI statement of August 19, 2022: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age”. What you need to know: NACI summary of recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age.

This overview helps you identify the document. Always consult the current official publication for clinical recommendations.

Official document